My Cancer Genome: Genetically Informed Cancer Medicine

  • Home
  • DIRECT
  • About Us
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Anaplastic Large Cell Lymphoma
  • Basal Cell Carcinoma
  • Bladder Cancer
  • Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Colorectal Cancer
  • GIST
  • Gastric Cancer
  • Glioma
  • Inflammatory Myofibroblastic Tumor
  • Lung Cancer
  • Medulloblastoma
  • Melanoma
  • Myelodysplastic Syndromes
  • Neuroblastoma
  • Ovarian Cancer
  • Prostate Cancer
  • Rhabdomyosarcoma
  • Thymic Carcinoma
  • Thyroid Cancer
  • Molecular Medicine
    • Anticancer Agents
    • Circulating Tumor DNA
    • Detecting Gene Alterations in Cancers
    • Immunotherapy in Cancer
    • Overview of Targeted Therapies for Cancer
    • Pathways
    • Types of Molecular Tumor Testing
  • Take Our Survey
  • Glossary
  • News
  • Our Team
  • Acknowledgements

Hormone Signaling

The steroid hormone cell signaling functions in transcriptional activation and gene expression. The steroid hormone signaling pathway may be activated by steroid hormones, such as estrogen and progesterone, which bind to a steroid binding protein (SBP).

Hormone Signaling

Figure 1. Steroid hormones (e.g., estrogen, androgen, progesterone) travel through the bloodstream from an endocrine gland bound by a steroid binding protein (SBP). The steroid is released from the SBP and is transported across the extracellular membrane and into the cell where is binds a nuclear receptor (e.g., ESR1, AR, PGR). The steroid also binds a heat shock protein (HSP90), a chaperone protein that aids in protein folding. HSP90 dissociates, and the steroid and nuclear receptor cross the nuclear membrane. The steroid and nuclear receptor homodimerize and bind to the hormone response element (HRE) within the promoter of a gene, which activates gene transcription and promotes cell growth and survival. Specific nodes in the pathway that are therapeutically actionable are noted. Click here to open a larger version of this image in a new window.

Downstream Pathways

  • Cell cycle control

Diseases in Which Pathway is Aberrantly Activated

  • Breast cancer
  • Ovarian cancer
  • Prostate cancer

Therapies That Target This Pathway

  • Conversion enzyme inhibitors
    • Aromatase inhibitors
  • HSP90 inhibitors
  • Steroid receptor inhibitors
    • Androgen receptor antagonists
    • Estrogen receptor antagonists
    • Selective estrogen receptor modulators (SERMs)
    • Selective estrogen receptor degraders (SERDs)
    • Selective androgen receptor modulators (SARMs)

Genes Involved in the Pathway

  • AR
  • ESR1
  • LRP1B
  • PGR
  • TSHR

Last Updated: May 24, 2016

Disclaimer: The information presented at MyCancerGenome.org is compiled from sources believed to be reliable. Extensive efforts have been made to make this information as accurate and as up-to-date as possible. However, the accuracy and completeness of this information cannot be guaranteed. Despite our best efforts, this information may contain typographical errors and omissions. The contents are to be used only as a guide, and health care providers should employ sound clinical judgment in interpreting this information for individual patient care.

  • MCG Home |
  • About Us |
  • Acknowledgments |
  • Give |
  • Site Map |
  • Legal |
  • APIs and Licensing
My Cancer Genome is managed by the Vanderbilt-Ingram Cancer Center   Copyright © 2010 - 2017 MY CANCER GENOME